Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 01, 2022
PI3 kinase alpha and delta promote hematopoietic stem cell activation.
Journal: JCI insight
Published: May 24, 2019
MSI2 is required for maintaining activated myelodysplastic syndrome stem cells.
Journal: Nature communications
Published: July 29, 2015
Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110α.
Journal: The Journal of clinical investigation
Published: March 15, 2013
STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2.
STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2.
Journal: Cancer research
Published: November 15, 2012
Hematopoietic stem cells lacking Ott1 display aspects associated with aging and are unable to maintain quiescence during proliferative stress.
Journal: Blood
Published: April 12, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026